Regenacy Pharmaceuticals
PrivateLast Round
Series B
Aug 24, 2022
Total Funding Raised
$39.3M
Company Overview
Regenacy Pharmaceuticals is a biopharmaceutical company that develops innovative therapeutic drugs using a novel, disease-modifying approach to treat peripheral neuropathy and related conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenacy Pharmaceuticals Comparables
Compare Regenacy Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Augustine Therapeutics | 91% | |
| Novaremed AG | 83% | |
| WinSanTor | 81% | |
Regenacy Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 24, 2022 | ||||
| Series A | Mar 25, 2020 |
Regenacy Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series B, Series A |
| Bencao Capital | Series A, Series B |
| Yonjin Capital | Series A |
| Viva Biotech | Series A |
| TA YA VENTURE HOLDINGS LIMITED | Series A |
| Yonjin Capital | Series A |
| Cobro Ventures | Series A, Series B |
Regenacy Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regenacy Pharmaceuticals's valuation, stock price, and market status.